Association of plasma B-type natriuretic peptide levels with shunt size in young adults with atrial septal defect

Echocardiography

Volumn 28, Issue 2, 2011, Pages 243-247

  Uz, Omer ^a   Aparci, Mustafa ^a   Acar, Gurkan ^a   Kardesoglu, Ejder ^a   Kaplan, Onur ^b   Yiginer, Omer ^a   Isilak, Zafer ^a   Ozcelik, Fatih ^c   Cebeci, Bekir Sitki ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Gumussuyu Military Hospital   (Turkey)

Author keywords

atrial septal defect; brain natriuretic peptide; young adult

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART INDEX; HEART PERFORMANCE; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC CIRCULATION; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; VALIDITY;

BIOLOGICAL MARKERS; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 79551564923     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2010.01285.x     Document Type: Article

References (22)

1. Muta H, Ishii M, Maeno Y, et al,: Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 2002; 91: 649-652.
2. Schoen SP, Zimmermann T, Kittner T, et al,: NT-proBNP correlates with right heart haemodynamic parameters and volumes in patients with atrial septal defects. Eur J Heart Fail 2007; 9: 660-666.
3. Cetin I, Tokel K, Varan B, et al,: Evaluation of right ventricular function by using tissue Doppler imaging in patients after repair of tetralogy of fallot. Echocardiography 2009; 26: 950-957.
4. Nagaya N, Nishikimi T, Uematsu M, et al,: Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Am Heart J 1998; 136: 297-301.
5. Eerola A, Jokinen E, Pihkala JI,: Serum levels of natriuretic peptides in children with various types of loading conditions. Scand Cardiovasc J 2009; 43: 187-193.
6. Mir TS, Falkenberg J, Friedrich B, et al,: Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease. Cardiol Young 2005; 15: 396-401.
7. Kunii Y, Kamada M, Ohtsuki S, et al,: Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 2003; 57: 191-197.
8. Ding J, Ma G, Huang Y, et al,: Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect. Cardiovasc Ultrasound 2008; 6: 35.
9. Ozhan H, Albayrak S, Uzun H, et al,: Correlation of plasma B-type natriuretic peptide with shunt severity in patients with atrial or ventricular septal defect. Pediatr Cardiol 2007; 28: 272-275.
10. Schiller NB, Shah PM, Crawford M, et al,: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
11. Wong SP, Otto CM,: Echocardiographic findings in acute and chronic pulmonary disease. In, Otto CM, (ed): The Practice of Clinical Echocardiography. Philadelphia, W.B. Saunders Company, 2002, p. 747.
12. Sanders SP, Yeager S, Williams RG,: Measurement of systemic and pulmonary blood flow and QP/QS ratio using Doppler and two-dimensional echocardiography. Am J Cardiol 1983; 51: 952-956.
13. Tayyareci Y, Tayyareci G, Tastan CP, et al,: Early diagnosis of right ventricular systolic dysfunction by tissue Doppler-derived isovolumic myocardial acceleration in patients with chronic obstructive pulmonary disease. Echocardiography 2009; 26: 1026-1035.
14. Koch A, Zink S, Singer H,: B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J 2006; 27: 861-866.
15. McDonagh TA, Cunningham AD, Morrison CE, et al,: Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 2001; 86: 21-26.
16. Talwar S, Siebenhofer A, Williams B, et al,: Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal pro BNP. Heart 2000; 83: 278-282.
17. Tulewski II, Groenink M, Van Der Wall EE, et al,: Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: Correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001; 86: 27-30.
18. Book WM, Hott BJ, McConnell M,: B-type natriuretic peptide levels in adults with congenital heart disease and right ventricular failure. Am J Cardiol 2005; 95: 545-546.
19. Trojnarska O, Szyszka A, Gwizdala A, et al,: Evaluation of exercise capacity with cardiopulmonary exercise testing and type B natriuretic peptide concentrations in adult patients with patent atrial septal defect. Cardiology 2006; 106: 154-160.
20. Tei C, Nishimura RA, Seward JB, et al,: Noninvasive Doppler-derived myocardial performance index: Correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997; 10: 169-178.
21. Perlowski AA, Aboulhosn J, Castellon Y, et al,: Relation of brain natriuretic peptide to myocardial performance index in adults with congenitalheart disease. Am J Cardiol 2007; 100: 110-114.
22. Yasuoka K, Harada K, Toyono M, et al,: Tei index determined by tissue Doppler imaging in patients with pulmonary regurgitation after repair of tetralogy of Fallot. Pediatr Cardiol 2004; 25: 131-136.